Integrin-KCNB1 potassium channel complexes regulate neocortical neuronal development and are implicated in epilepsy

Area of Science:

• Neuroscience
• Developmental Biology
• Molecular Biology

Background:

• Potassium (K+) channels, including KCNB1 (Kv2.1), are present during prenatal brain development but their roles are unclear.
• Developmental and epileptic encephalopathies (DEEs) are severe neurological disorders with genetic origins.
• Voltage-gated ion channels can contribute to developmental disorders through non-conducting mechanisms.

Purpose of the Study:

• To investigate the function of KCNB1 (Kv2.1) in neocortical development.
• To determine if KCNB1 mutations cause developmental channelopathies.
• To explore the therapeutic potential of targeting Integrin-K+ channel complexes (IKCs).

Main Methods:

• Utilized KCNB1 null mice and KCNB1 R312H knock-in mice modeling human DEEs.
• Analyzed neuronal migration, morphology, and synaptic connectivity in developing and adult brains.
• Investigated KCNB1 channel interactions with integrin α5β5 and signaling pathways in vitro.

Main Results:

• KCNB1 deficiency or mutation (R312H) impaired glutamatergic neuron migration and caused persistent neuromorphological and synaptic defects.
• Affected mice exhibited seizures, anxiety, and compulsive behaviors, mimicking DEE symptoms.
• KCNB1 channels form complexes with integrins α5β5 (IKCs), and R312H mutation impaired IKC signaling.
• Pharmacological treatment with Angiotensin II rescued neuronal abnormalities in vitro.

Conclusions:

• KCNB1 plays a critical, non-conducting role in neuronal development via Integrin-K+ channel complexes (IKCs).
• Genetic KCNB1 mutations can cause severe developmental channelopathies leading to neurological deficits.
• Targeting IKC signaling offers a potential therapeutic strategy for KCNB1-related developmental disorders.